These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 27094357)

  • 1. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
    Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
    Meng F; Asghar S; Gao S; Su Z; Song J; Huo M; Meng W; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2015 Oct; 134():88-97. PubMed ID: 26162977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
    Madane RG; Mahajan HS
    Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside improves physicochemical properties and bioavailability of curcumin-loaded nanostructured lipid carrier.
    Vijayakumar A; Baskaran R; Maeng HJ; Yoo BK
    Arch Pharm Res; 2017 Jul; 40(7):864-874. PubMed ID: 28712035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
    Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
    Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
    Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
    Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice.
    Puglia C; Frasca G; Musumeci T; Rizza L; Puglisi G; Bonina F; Chiechio S
    Eur J Pharm Biopharm; 2012 Jun; 81(2):288-93. PubMed ID: 22504443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
    Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
    Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation.
    Masjedi M; Azadi A; Heidari R; Mohammadi-Samani S
    J Pharm Pharmacol; 2020 Oct; 72(10):1341-1351. PubMed ID: 32579251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
    Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation.
    Sadegh Malvajerd S; Azadi A; Izadi Z; Kurd M; Dara T; Dibaei M; Sharif Zadeh M; Akbari Javar H; Hamidi M
    ACS Chem Neurosci; 2019 Jan; 10(1):728-739. PubMed ID: 30335941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
    Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
    Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.